OR WAIT 15 SECS
© 2020 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2020 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
October 07, 2020
In a recent video from OncLive, Erika P. Hamilton, MD, highlights the initial findings from the ongoing phase 1b/2 LIO-trial in advanced metastatic tumors.
September 22, 2020
According to new research, women with ductal carcinoma in situ (DCIS) are more than three times as likely to suffer from breast cancer mortality than women in the general population.
Postmenopausal women are significantly more likely to meet criteria for metabolic syndrome than are premenopausal women, according to a cross-sectional analysis of women aged 45 to 85.
September 16, 2020
Officials from the Food and Drug Administration (FDA) issued a safety alert on Sept. 8 about potential efficacy and safety concerns with Tecentriq in combination with Paclitaxel for breast cancer treatment.
August 18, 2020
Results from the study showed antitumor activity and safety to be similar to olaparib and durvalumab monotherapy outcomes.
According to the findings, mammograms declined by 89.2% in April of this year.
Findings from a new study by Australian researchers suggest that physical activity should be incorporated into cancer care during and beyond treatment.
August 04, 2020
The lack of data on the possible connection between race and breast cancer prognosis is what led a group of Mount Sinai researchers to conduct this new multicenter, cross-sectional study.
July 30, 2020
A study from the Long Island Breast Cancer Study Project (LIBCSP) investigated the association between menopausal hormone therapy (MHT) and mortality outcomes among breast cancer survivors.
July 29, 2020
New research shows that, when seeking treatment for cancer-related fatigue, breast cancer survivors underutilize recommendations.